Tranexamic acid (TXA) is one of the newer ingredients in the pigmentation space, and it's generating real excitement. Originally developed as an anti-hemorrhagic drug (it stops bleeding by inhibiting plasminogen), dermatologists noticed that patients taking it orally also saw improvements in their melasma. That observation led to research into topical TXA for pigmentation.
The early results are promising. But "promising early results" is not the same as "proven," and we think the distinction matters. Here's what we know, what we don't, and whether TXA deserves a place in your routine right now.
How it works
TXA interrupts the pigmentation pathway at a different point than most other ingredients. When your skin is exposed to UV light or experiences inflammation (like from acne), it activates the plasminogen/plasmin system. This cascade triggers melanocytes to produce more melanin. TXA blocks this pathway by inhibiting plasminogen activator, which means it stops one of the signals that tells your skin to make more pigment.
This is distinct from how other pigmentation ingredients work:
- Azelaic acid inhibits tyrosinase (the enzyme that makes melanin).
- Niacinamide blocks melanosome transfer (stops pigment from reaching skin cells).
- Hydroquinone is cytotoxic to hyperactive melanocytes (kills the cells producing excess pigment).
- TXA blocks the upstream signal that triggers melanin production in the first place.
Because they work through different mechanisms, TXA can theoretically complement other pigmentation treatments rather than compete with them.
Topical vs oral
This distinction is critical and often glossed over in skincare content.
Oral TXA is prescribed by dermatologists for stubborn melasma at 250-500mg twice daily. It enters the bloodstream and works systemically. The evidence for oral TXA in melasma is stronger than for topical. Multiple controlled trials show significant improvement. However, because TXA affects blood clotting, oral use carries risks: it's contraindicated for people with a history of blood clots, stroke, or certain heart conditions. It requires blood work monitoring and medical supervision.
Topical TXA (2-5% in serums and creams) works locally. Systemic absorption is minimal. It does not carry the clotting risks of oral TXA. This is what's available in OTC skincare products. The evidence is newer and smaller in scale, but growing.
When skincare brands cite TXA studies, check whether the study used oral or topical TXA. Some of the most impressive results come from oral studies, which don't translate directly to a 3% serum you apply on your face.
The study worth knowing about
Key finding
Niacinamide + TXA + Vitamin C performed comparably to 4% hydroquinone for pigmentation.
A 2025 study (Rocio B, et al.) compared a combination serum of tranexamic acid, niacinamide, and vitamin C against 4% hydroquinone for facial hyperpigmentation. After 12 weeks, both groups showed similar improvement in pigmentation scores. The combination serum had fewer side effects. This is one study, and it needs replication, but it suggests TXA-based combinations could eventually offer an alternative to hydroquinone.
Why this matters for Indian skin: hydroquinone works, but it has real limitations. It can't be used for more than 3-4 months at a time, it can cause ochronosis (paradoxical darkening) with prolonged use, and it's not safe during pregnancy. If a TXA-based combination can match hydroquinone's efficacy without these drawbacks, that's significant for the millions of Indians dealing with melasma and PIH.
The honest caveat: this is one study. The sample size was moderate. It needs independent replication across different populations and skin types before we can call it an established alternative. The result is promising, not proven.
What we don't know yet
Being transparent about limitations is important, especially with newer ingredients where the hype cycle is strong.
- Long-term safety data for topical TXA is limited. Most studies are 12-16 weeks. We don't have multi-year data on daily topical use.
- Optimal concentration for topical use is not settled. Studies have used anywhere from 2% to 5%. We don't know the dose-response curve well enough to say "3% is ideal" with confidence.
- How it works for different types of pigmentation is still being established. Melasma data is the strongest. PIH data is growing. Sun damage pigmentation data is sparse.
- Whether topical TXA works independently or only in combination is unclear. The strongest topical results come from combination products (TXA + niacinamide + vitamin C). Whether TXA alone, applied topically at 3%, does enough on its own is less clear.
Should you use it now?
If you're dealing with melasma or persistent PIH and you've already tried niacinamide, azelaic acid, and consistent sunscreen use, adding a topical TXA serum is reasonable. The safety profile is good, the early data is encouraging, and it works through a mechanism different from ingredients you're likely already using.
If you're just starting to address pigmentation, begin with the proven foundations: daily sunscreen, niacinamide (5%), and azelaic acid (15-20% prescription). These have decades of data supporting them. TXA is an addition to that foundation, not a replacement.
If your dermatologist has recommended oral TXA for melasma, that decision is based on stronger evidence and should be followed under their supervision.
How to use topical TXA
- Apply 2-5% TXA serum to clean skin, morning or evening.
- It can be layered with niacinamide and vitamin C (the combination has the best data).
- Does not increase sun sensitivity, but sunscreen is still essential because UV exposure is the primary driver of the pigmentation you're trying to treat.
- Expect 8-12 weeks before visible results. Take progress photos under consistent lighting.
- Generally well-tolerated. Mild tingling is uncommon but possible.
Common questions
Is tranexamic acid safe for Indian skin?
Yes. Topical TXA at 2-5% is generally well-tolerated across all skin tones, including Fitzpatrick IV-V (most Indian skin types). It does not increase sun sensitivity and does not carry the risk of paradoxical darkening (ochronosis) that hydroquinone does with prolonged use. Oral TXA is a different conversation and should only be taken under medical supervision due to potential effects on blood clotting.
How long does tranexamic acid take to work?
Most studies show visible improvement in pigmentation at 8-12 weeks of consistent use. Some studies report initial changes as early as 4 weeks, but meaningful, noticeable results typically take 2-3 months. This is similar to most pigmentation treatments. If you don't see any change after 12 weeks, it may not be the right ingredient for your specific type of pigmentation.
Tranexamic acid vs niacinamide for pigmentation?
They work through different mechanisms and can be used together. Niacinamide (5%) inhibits melanosome transfer, has decades of research, and is proven across multiple studies. TXA inhibits the plasminogen pathway that triggers melanin production after UV exposure or inflammation. TXA has stronger early data specifically for melasma. Niacinamide has a broader, deeper evidence base overall. If forced to choose one, niacinamide is the safer bet because the research is more established. If you want to try TXA, using it alongside niacinamide is reasonable.
Sources
- Rocio B, et al. Efficacy of a topical formulation containing tranexamic acid, niacinamide, and vitamin C vs 4% hydroquinone in facial hyperpigmentation. J Cosmet Dermatol. 2025;24(1):e15478.
- Ebrahimi B, Naeini FF. Topical tranexamic acid as a promising treatment for melasma. J Res Med Sci. 2014;19(8):753-757.
- Kim SJ, et al. Efficacy of topical tranexamic acid in the treatment of melasma. Ann Dermatol. 2016;28(1):78-82.
- Bala HR, et al. Oral tranexamic acid for the treatment of melasma: a review. Dermatol Surg. 2018;44(6):814-825.
- Kanechorn Na Ayuthaya P, et al. Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial. J Cosmet Laser Ther. 2012;14(3):150-154.